What the research actually shows about why patients with chronic gut dysfunction react badly to the most widely recommended supplement in functional medicine, and where the actual lesion lives.
The Pattern You Are Living
You have been told for years that you need probiotics. Your doctor told you. Your functional medicine practitioner told you. The forum told you. The Instagram algorithm told you. The supplement company told you. Every podcast told you.
So you tried them. You started with a basic Lactobacillus and Bifidobacterium blend from the pharmacy. Within three days you felt strange. The bloating got worse. The brain fog deepened. Your skin flushed in a way it had not done before. You stopped and felt better. You assumed it was the wrong brand.
So you tried again. This time the expensive one, the multi strain formula with billions of CFU and the resistant capsule. Within a week the gut symptoms intensified, the histamine reactions came back, the sleep fragmented, and a new symptom you did not have before appeared. You stopped again. You felt better again.
So you tried a sporebiotic. You were told these were different, that they were not lactic acid bacteria, that they would survive transit and modulate the immune system. The first dose gave you a headache. The third dose triggered an episode of anxiety you had not felt in months. You stopped.
So you tried Saccharomyces boulardii. This one was tolerated. You felt nothing remarkable but you felt nothing bad. You assumed this was progress. You kept it on board for six months. Nothing changed.
So you tried the L. reuteri yogurt protocol your friend insisted had cured her bloating. You made the yogurt. You ate a small portion. The brain fog returned within two hours, your face flushed, your heart raced, and you spent the next two days in a flare. You assumed your friend’s gut was different from yours.
So you tried a soil based organism. So you tried Akkermansia. So you tried a postbiotic. So you tried a different brand, and another brand, and another brand. Every time the same pattern. Either no effect or a worsening you could not explain. Every time someone told you to push through the die off. Every time you did and got worse.
You assumed it was you. You assumed your gut was uniquely broken. You assumed you had not found the right strain yet. You assumed you needed more, or less, or a different delivery system, or a different time of day. You assumed your microbiome was the most dysfunctional one in the room.
It is not.
The reason your probiotic experience has been a sequence of failures is not because your gut is uniquely broken and not because the right strain has not yet been invented. The reason is that the entire premise of the intervention is wrong for your physiology.
The Question Nobody Is Asking
For thirty years the gut health field has been asking one question. What microbes are missing, and how do we put them back?
This is the wrong question.
The right question is the one almost nobody asks. What state is your gut in that allows or prevents the normal microbial ecology from establishing itself? Microbes are not the cause of the dysbiotic state you are in. They are the readout of it. The organisms growing in your colon right now are the ones that thrive in the environment your colonocytes are currently producing. Change the environment and the microbes change. Change only the microbes and the environment selects them out within days or actively reacts to them in ways that worsen your symptoms.
Probiotics are an attempt to install new tenants into a building whose foundation has collapsed. The tenants either cannot move in, get evicted within hours, or actively damage the structure further during their brief stay. The field has spent three decades looking at the tenants. The lesion is in the building.
This piece explains the six mechanisms by which probiotics actively make chronic illness worse, why patients with MCAS, SIBO, histamine intolerance, and long COVID are uniquely vulnerable, and why the conventional reframing of “you just have not found the right strain” misses what the research has been saying for over a decade.
Mechanism One: The Lactate Problem and Why Your Brain Fog Spikes On Probiotics
Most commercial probiotic strains belong to a single metabolic class. They are lactic acid bacteria. Lactobacillus species, Bifidobacterium species, Streptococcus thermophilus, Pediococcus, Leuconostoc. Their primary fermentation product is lactate.
In a healthy colon this is not a problem. Lactate produced by these organisms is rapidly consumed by a second class of bacteria called lactate utilizers. The two main genera are Eubacterium hallii and Anaerostipes. These organisms take the lactate, oxidize it through their own metabolism, and produce butyrate as the end product. The lactate never accumulates because it is intercepted before it can.
The problem is that lactate utilizers are exquisitely sensitive to host conditions. They are obligate anaerobes. They require the colonic lumen to be physiologically hypoxic, which it only is when colonocytes are oxidizing butyrate at high rates and consuming oxygen at the epithelial border. In compromised hosts these organisms are dramatically depleted. The lactate utilizers are among the first community members to disappear when colonocyte function fails.
When you swallow a lactate producing probiotic into this environment, the lactate accumulates. There is nothing to consume it. The pH drops in the local environment. The colonocytes themselves, already bioenergetically compromised, are now asked to absorb and clear large quantities of lactate at the same time they are failing to oxidize butyrate, the same time they are losing the ability to maintain hypoxia, and the same time they are signaling distress through inflammatory and senescence pathways.
It gets worse. Many lactic acid bacteria produce a specific stereoisomer called D lactate, the mirror image of the L lactate that human metabolism is built to handle. Humans have an enzyme called D lactate dehydrogenase that can clear D lactate, but it operates slowly and is easily overwhelmed. D lactate that escapes hepatic clearance crosses the blood brain barrier. In the brain it produces a recognizable syndrome called D lactic acidosis with confusion, ataxia, slurred speech, profound cognitive impairment, and emotional flattening.
Frank D lactic acidosis is recognized clinically in short bowel syndrome patients. What is not recognized is that a subclinical version of this same phenomenon occurs every time a patient with compromised colonocyte function takes a high dose lactic acid probiotic. The brain fog that hits within hours of dosing, the strange detached feeling, the inability to find words, the slowed processing, these are not coincidences. They are D lactate crossing the blood brain barrier from a colon that has lost its capacity to consume lactate.
You can see this on testing. Organic acids panels measure lactate in urine. Patients who react badly to probiotics consistently show elevated lactate markers, sometimes alongside elevated arabinose and other fungal metabolites because the same dysbiotic environment selects for both lactate accumulation and opportunistic fungal overgrowth. The marker that tells you a patient should not be taking lactic acid probiotics is sitting on their OAT and almost no one is reading it that way.
Mechanism Two: The Histamine Problem and Why Your Reactions Are Not Random
Probiotic strains are not biochemically uniform. They differ enormously in what they produce, and one of the most important differences is whether they generate histamine.
Histamine production in bacteria is mediated by an enzyme called histidine decarboxylase, which converts dietary histidine into histamine. Some strains carry this enzyme and produce histamine prolifically. Others lack it entirely. A third group produces enzymes that actively degrade histamine in the gut lumen.
The strains that produce histamine include Lactobacillus casei, Lactobacillus bulgaricus, Lactobacillus helveticus, Lactobacillus delbrueckii, Lactococcus lactis, and several Streptococcus species used in fermented dairy. These are the workhorse strains in yogurt cultures, kefir starters, and many commercial probiotic blends.
The strains that degrade histamine include certain Lactobacillus reuteri strains, certain Lactobacillus salivarius strains, and Bifidobacterium infantis. The complication is that the strain level matters enormously. Two products labeled as L. reuteri can contain entirely different strains with opposite biochemical behavior. Almost no commercial probiotic provides strain level genomic data on histamine production.
For a patient with MCAS, with histamine intolerance, with DAO deficiency, with perimenopausal estrogen mast cell amplification, or with any of the dozen other conditions in which histamine clearance is compromised, taking a high CFU dose of a histamine producing strain is the supplement equivalent of pouring gasoline on a fire. The histamine produced in the gut crosses the failing intestinal barrier, is not adequately cleared by the depleted DAO at the mucosa, enters portal circulation, escapes the also impaired HNMT pathway in the liver, and reaches systemic mast cells in a body that is already sensitized.
The reaction patients describe within an hour of dosing, the flushing, the racing heart, the gut cramping, the brain fog, the hives, the throat tightness, is not psychosomatic and is not an adjustment reaction. It is bacterially produced histamine reaching an immune system that has lost the capacity to clear it.
Beyond histamine, fermentation by many of these same organisms also produces tyramine, putrescine, cadaverine, and other biogenic amines that compete for the same clearance enzymes and produce overlapping symptoms. This is why patients with histamine intolerance often also react to aged cheese, cured meats, kombucha, kefir, kimchi, sauerkraut, and bone broth. The same enzymatic chemistry runs in fermented foods as in probiotic capsules. The patient is reacting to the bacterial metabolic output in both cases.
Mechanism Three: The Wrong Site Problem and Why Most Probiotics Never Reach The Place You Need Them
When you swallow a probiotic capsule, where exactly do you think those bacteria are going?
Most commercial products are engineered to survive stomach acid through enteric coating or microencapsulation. The point of these technologies is to deliver live organisms past the stomach and into the small intestine. The small intestine is where most of the absorption and immune sampling occurs and is where many probiotic products are biologically designed to colonize.
But the small intestine is not where the dysbiosis lives in most chronic illness patients. The dysbiosis lives in the colon. The colon is downstream, with a transit window of hours to days, a fundamentally different oxygen environment, a different pH, different bile acid concentrations, and a totally different microbial niche structure. Probiotic strains designed to survive transit and act in the small intestine arrive in the colon in much smaller numbers than the label suggests, are biochemically poorly adapted to the colonic environment, and pass through within twenty four to forty eight hours without establishing residence.
This has been demonstrated experimentally. The Weizmann Institute work led by Eran Elinav and Eran Segal in 2018 and the subsequent papers in the years since showed that probiotic colonization is highly individualized. In some hosts the strains were able to transiently take residence in mucosal tissue. In others the resident microbiome resisted colonization completely. The probiotic passed through without integrating. In a third group, probiotic administration following antibiotic exposure actively delayed the recovery of the native microbiome compared to no intervention at all. In other words, in a subset of patients probiotics made the dysbiosis last longer than doing nothing would have.
For patients with SIBO this problem is worse than wasted. Many SIBO patients have small intestinal overgrowth driven by motility failure, ileocecal valve dysfunction, or migrating motor complex impairment. The bacteria that should be in the colon are instead resident in the small intestine where their fermentation activity produces hydrogen, methane, or hydrogen sulfide and causes the symptoms of bloating, distension, pain, and reflux. Adding more bacteria via the oral route, especially bacteria designed to colonize the small intestine, is the precise opposite of what this physiology needs. You are adding to an overgrowth.
The patient who reports that every SIBO protocol she has been put on has failed, that probiotics make her bloating worse, that the prokinetic helps temporarily but the symptoms return, is showing you the signature of someone whose underlying motility lesion has never been addressed and whose probiotic dosing has been adding fuel to the small intestinal overgrowth for years.
Mechanism Four: The Host Environment Problem and Why The Microbes Cannot Take Hold
This is the central mechanism. The other five are downstream of it.
Your colon is a habitat. Habitats are defined by their physical and chemical conditions. The colon habitat that supports a healthy obligate anaerobic microbiome is defined by four properties. First, near total absence of oxygen at the mucosal surface, called physiologic hypoxia. Second, a steady supply of fermentable substrate reaching the colon in the form of mucin from goblet cells and resistant starches from the diet. Third, an intact mucus layer that separates bacteria from epithelium and creates microhabitats for cross feeding. Fourth, a tight epithelial barrier that prevents bacterial translocation into the lamina propria and keeps the local immune system in tolerance mode.
All four of these properties are produced by the colonocyte. The cells lining your colon are not passive observers of the microbiome. They are the engineers of its environment. They consume oxygen aggressively through mitochondrial oxidation of butyrate, which keeps the lumen anaerobic. They secrete mucin precursors that feed the bacteria immediately upstream of the barrier. They maintain tight junctions and produce antimicrobial peptides that shape which organisms can persist near the surface. They sit in metabolic dialogue with the bacteria, sending and receiving signals that keep the entire system in equilibrium.
When colonocytes fail bioenergetically, all four properties collapse simultaneously. Butyrate oxidation drops. Oxygen leaks into the lumen. Facultative anaerobes that can tolerate oxygen, the Enterobacteriaceae, expand. Obligate anaerobes that produce butyrate, Faecalibacterium prausnitzii, Roseburia, and the Eubacterium genera, retract because their environment is no longer hospitable. The mucus layer thins. The barrier loosens. The immune system shifts from tolerance to surveillance. The microbiome you started with is gradually replaced by the microbiome that thrives in a damaged colonocyte environment.
This is the central insight of the Host Capacity Model. The dysbiosis is not the disease. The dysbiosis is the readout of a host that has lost the capacity to maintain its own ecology.
What happens when you take a probiotic into a colon that is in this state? The probiotic encounters an environment that is biochemically hostile to it. Oxygen is present where it should not be, which is toxic to obligate anaerobic species and stressful to many of the lactobacilli that prefer microaerophilic conditions. The pH is wrong because butyrate is not being produced. The substrate they need is being consumed by competing facultative organisms. The mucus layer they would normally adhere to has thinned to the point that mucin associated colonization is impossible. The immune system at the epithelium is in a state of activation that targets transient organisms rather than tolerating them.
So the probiotic does not colonize. It cannot. It does the only thing left available to it, which is pass through. While passing through it does several things you do not want. It adds to the bacterial load the failing barrier has to manage. It releases cellular components as cells die. It disturbs the equilibrium the resident dysbiotic community has reached. It triggers immune reactions because it is a foreign biological signal arriving at an already activated mucosal surface.
You feel this within hours or days as worsening symptoms. The field tells you this is a Herxheimer reaction or die off. It is neither. It is your already inflamed gut responding to a large biological challenge it cannot accommodate.
The implication of this mechanism is the single most important reframing of gut health intervention available. The microbiome will not be repaired by adding microbes. The microbiome will be repaired by restoring the host environment that selects for the right microbes. When colonocyte bioenergetics is restored, oxygen is consumed again, mucus is rebuilt, barrier seals, and immune tolerance returns, the obligate anaerobes that produce butyrate expand on their own from the small residual populations that were always there waiting. No external bacteria need to be added. The colon repopulates itself when the architecture is rebuilt.
This is why the patients I have worked with who address the host capacity layer rather than the microbe layer get long term resolution while the patients who chase strain by strain corrections through probiotic experimentation stay in the chronic illness state for years.
Mechanism Five: The Endotoxin Shedding Problem
A probiotic capsule contains billions of bacterial cells. Many of them are not alive by the time you ingest them. Manufacturing, storage, shipping, and shelf time produce significant cell death even in well preserved products. The label CFU count is a snapshot, not a current state.
Dead bacterial cells matter more than people realize. Bacterial cell walls contain components that the immune system reads as threat signals. Gram positive bacteria including all Lactobacillus and Bifidobacterium species release lipoteichoic acid from their cell walls. Lipoteichoic acid is a strong agonist of toll like receptor 2, which is one of the central pattern recognition receptors that triggers inflammatory cascades through NF kappa B activation. Gram negative bacterial contamination, which occurs at low but detectable levels in many products, releases lipopolysaccharide, which is the canonical activator of toll like receptor 4 and the most powerful inflammatory trigger in the bacterial world.
In a healthy gut with an intact barrier and adequate intestinal alkaline phosphatase activity, these signals are contained at the mucosa, dephosphorylated, and tolerated. In a chronic illness gut with low IAP, with mucosal barrier compromise, and with already activated mast cells and dendritic cells in the lamina propria, every dose of a probiotic delivers a meaningful additional load of these pattern recognition signals into a tissue that is already inflamed. The translocation that follows produces systemic immune activation that the patient experiences as fatigue, body aches, brain fog, mood drop, and intensification of every existing symptom.
The patient who reports she feels like she has the flu for two days after starting a new probiotic is not describing a healing crisis. She is describing acute endotoxin and lipoteichoic acid translocation from a probiotic she could not tolerate.
This mechanism is particularly destructive in long COVID, in CIRS, in mold illness, and in any condition in which the patient’s baseline immune state is already activated by ongoing antigen exposure. The probiotic dose is not a clean intervention. It is an additional immunological insult layered on top of one that is already failing to resolve.
Mechanism Six: The Quorum Disruption And Resistance Gene Transfer Problem
Bacteria do not exist as isolated organisms. They exist as communities held together by chemical signals exchanged between cells, a phenomenon called quorum sensing. Acyl homoserine lactones and other small molecules allow bacteria to count their neighbors, coordinate gene expression, and shift between solitary and group behaviors. A bacterial community in equilibrium has stable quorum signaling patterns. Disrupt those signals and gene expression shifts in unpredictable ways.
When you administer a high CFU probiotic dose into an existing colonic community, you do not just add organisms. You add chemical signals that the resident community interprets in ways that may not match the intention of the intervention. Some resident pathobionts respond to quorum perturbation by upregulating virulence factor expression. The benign passenger E. coli that has been quietly resident in your colon for years can shift toward more aggressive behavior when its quorum equilibrium is disrupted. This is a documented phenomenon in laboratory research and is almost never discussed in the clinical conversation about probiotics.
There is a second concern that the field has largely ignored. Many commercial probiotic strains carry antibiotic resistance genes on mobile genetic elements. Studies dating back fifteen years have shown that probiotic Lactobacilli can serve as reservoirs of resistance genes including those for vancomycin, tetracycline, and erythromycin, and that these genes can be transferred horizontally to pathogens in the gut through conjugation and transduction. In a healthy person with intact immune surveillance and minimal pathogen pressure this is a theoretical concern. In a chronic illness patient with disrupted barrier function, ongoing low grade infection or recurrent antibiotic use, this is an active mechanism by which probiotic supplementation contributes to the persistence of pathogenic organisms in the gut.
You will not see this on a standard panel. The horizontal transfer of resistance genes is invisible to GI MAP, GI Effects, and even most metagenomic sequencing because the resistance genes themselves are short and easy to miss without targeted analysis. But the phenomenon is real and is part of the reason that probiotic exposure in chronic illness patients does not show the expected microbial benefit even when measured carefully.
The Convergence: One Upstream Lesion Producing Six Downstream Failures
All six mechanisms point to the same upstream lesion.
The host environment is compromised. The colonocyte cannot oxidize butyrate. The lumen is not adequately hypoxic. The barrier is leaky. The immune system at the mucosa is activated. The lactate utilizers and butyrate producers have retracted. The mucus layer is thin. The pH is wrong. The bile acid signaling is disturbed. The motility is impaired.
Into this environment we are throwing probiotics expecting them to do the work that the host cannot. They cannot. They never could. The framework that asks “what microbes are missing” cannot solve the problem because the missing microbes are missing precisely because the environment will not house them. Putting them back via the oral route is not just ineffective. It is actively harmful through the six mechanisms above. Lactate accumulates and crosses the blood brain barrier. Histamine producers add to the immune burden. Bacteria arrive at the wrong anatomical site. The host environment evicts them within hours. Their dead cells deliver endotoxin to an already inflamed barrier. Their quorum signals disturb the residents into more aggressive behavior. Their resistance genes pollute the community further.
The host is the architecture. Microbes follow architecture. Fix the architecture and the microbes return. Try to install new microbes into a collapsed architecture and you produce the suffering pattern that defines chronic illness.
This is what the Host Capacity Model has been arguing from its inception. The framing of dysbiosis as a microbial deficit to be corrected by microbial addition is the central error of the modern gut health field. It is not partially wrong. It is wrong at the level of premise. The biology runs the other direction.
Why You React To Some Strains And Not Others: Pattern Stratification
Once you understand the six mechanisms it becomes possible to predict which patients will react to which strains and why. I have observed four reactivity patterns across the cases I have worked with, and they map onto the mechanisms above with a precision that has clinical utility.
Pattern A is the lactate accumulator pattern. These patients react to virtually all Lactobacillus and Bifidobacterium strains within hours of dosing with brain fog, fatigue, slowed thinking, and a flat affect that lifts when the probiotic is stopped. They tolerate Saccharomyces boulardii, which is a yeast and does not produce lactate, and they tolerate the soil based organisms incompletely. Their organic acids panels show elevated urinary lactate, often elevated arabinose, and frequently elevated 3 hydroxybutyrate or other ketogenic markers that signal colonocyte fuel substrate shift. The lesion is colonocyte mitochondrial dysfunction with collapse of the lactate utilizing community. They cannot consume the lactate the probiotic produces.
Pattern B is the histamine reactor pattern. These patients react to specific strains, with reactions that look like classic MCAS or histamine intolerance flares. Flushing, hives, racing heart, gut cramping, sometimes anxiety or panic within an hour of dosing. They typically tolerate Bifidobacterium infantis and react to Lactobacillus casei, bulgaricus, helveticus, and the dairy fermenter strains. They also react badly to kefir, kombucha, sauerkraut, and aged cheese in patterns that overlap their probiotic reactions. The lesion is histamine clearance failure compounded by bacterial histamine production. DAO activity may be low, HNMT methylation may be impaired, or both, and the dietary histamine load is already at threshold before the probiotic adds to it.
Pattern C is the endotoxin sensitive pattern. These patients react to all probiotics with a flu like response that lasts one to three days, including body aches, fatigue, low grade temperature elevation, joint pain, and mood drop. They often have a history of long COVID, mold illness, CIRS, recurrent EBV reactivation, or another condition in which the immune system is in a sustained activated state. The lesion is loss of mucosal tolerance with low intestinal alkaline phosphatase activity, mucosal barrier compromise, and elevated baseline TLR2 and TLR4 signaling. The probiotic delivers fuel to a fire that is already burning. These are often the same patients whose symptoms worsen on every gut intervention attempted and who improve dramatically when interventions are removed.
Pattern D is the small intestinal overgrowth pattern. These patients have classic SIBO symptoms with positive breath testing or strong clinical suspicion. They react to upper small intestinal colonizing probiotics with worsening of bloating, distension, and post prandial discomfort within forty eight hours of starting. The lesion is motility failure with reduced migrating motor complex activity, often combined with ileocecal valve dysfunction or post infectious enteric neuropathy. The probiotic is being added to an already overgrown environment. These patients are sometimes told they have died off from their treatment when in fact the probiotic itself is contributing to the overgrowth they are trying to correct.
A given patient often presents with two or three patterns simultaneously, which is why probiotic reactions are so unpredictable and why no strain seems to be tolerated consistently. The lactate problem and the histamine problem compound. The endotoxin problem amplifies both. The SIBO substrate problem makes everything worse. You are not failing to find the right strain. You are running an intervention that does not match the lesion you have.
The Right Sequence: What Actually Works
I will not give you a protocol here. Protocols are noise without diagnostic specificity, and giving generic dosing advice to readers I have not assessed is exactly the dynamic that has failed every patient who has tried the last twelve probiotic protocols she found on the internet. But I will tell you the sequence the framework dictates.
The first move is not to add bacteria. The first move is to restore the host. This means restoring colonocyte bioenergetics through targeted intervention at the mitochondrial layer, including the cofactors that are universally depleted in colonocyte stress states. It means resealing the barrier through targeted nutrient and signaling interventions that the failing cells can actually use. It means bringing oxygen consumption back online so that hypoxia returns to the lumen. It means restoring the substrates the resident butyrate producers need so they can expand from residual populations without external addition. It means addressing any active inflammatory drivers, whether food immunoreactivity, mast cell activation, mold exposure, persistent viral antigen, or chronic infection, that are keeping the immune system at the mucosa in surveillance mode.
When the host is restored, the microbiome rearranges itself. The Faecalibacterium that was reduced to one percent of the community expands to ten or twenty. The obligate anaerobes return from the small reservoirs in the proximal colon. The lactate utilizers re establish. The mucus layer thickens. The barrier seals. The immune system at the epithelium shifts from activation to tolerance. This process takes months in some patients and longer in others, but it happens reliably when the upstream lesion is addressed.
Probiotics, if they have a role at all, come in last, after the architecture is repaired, in the context of a host that can actually receive them, and only for narrow specific indications that require a strain the resident community has lost the capacity to regenerate on its own. In most patients no external probiotic is needed once the host capacity is restored. The community repopulates from within.
This is the inversion the field has not yet made. The microbiome is not the engine of the gut. The host is the engine. The microbiome is the exhaust signature.
What This Means For You
If you have reacted badly to probiotics, you are not broken. You are reading a signal correctly. Your body is telling you that the intervention does not match your physiology. The bloating, the brain fog, the flushing, the fatigue, the mood drop, the worsening of every symptom you started this protocol to fix, these are not failures of your gut to heal. They are accurate biological responses to an intervention that was designed for a problem you do not have.
The narrative that you have just not found the right strain has kept you cycling through brands for years. The narrative that you need to push through the die off has kept you tolerating worsening symptoms in pursuit of a benefit that will not come. The narrative that probiotics are universally helpful has kept the entire chronic illness community trying to solve a host capacity problem with a microbial intervention. None of this is your fault. The framing was wrong before you arrived.
If you stop the probiotic and feel better within days, that is not coincidence. That is the removal of a load your physiology could not accommodate. If you have been told the worsening is just adjustment, you are correct to be skeptical. Adjustment to a tolerable intervention does not look like worsening of every symptom you have. It looks like neutral or slight improvement that builds over weeks.
The work that actually changes your trajectory is upstream of the probiotic question. It is the work of mapping which patterns are driving your case, what the colonocyte status is, what the barrier is doing, where the immune activation is coming from, and what the host environment requires before any microbial addition is even appropriate. That work cannot be done from a Google search or a forum thread. It requires looking at your specific labs, your specific symptom timeline, your specific exposure history, and your specific physiology, and building the mechanistic case for what is actually happening in your gut.
This is what I do at Biomelogic. I look at your data through the Host Capacity Model framework, map which patterns are driving your case, identify which probiotic strains your physiology will and will not tolerate, and most importantly, build the upstream interventions that will restore your host environment so the microbiome can do what it is supposed to do without you having to swallow capsules trying to force it.
Working With Me
My consultation is six hundred and fifty dollars. It includes a full review of all the testing you have done, a live working session in which we go through the mechanistic case in detail, and a written summary you can share with your prescribing physician. I work with a small number of cases at a time because depth of analysis is the entire value of the work. I am not a clinician. I do not prescribe. I work alongside your treating physicians and help them see the upstream mechanism they have not been trained to see.
If you have been cycling through probiotic protocols for years and the answer has not arrived, the answer was never going to arrive through that channel. The answer lives one layer upstream of where you have been looking.
You can reach me at biomelogic@outlook.com to discuss whether your case is one I can help with. My waitlist is real but moving, and serious cases that fit the framework get prioritized.
The probiotic was never going to fix you. The host capacity was always the lesion. Once you see this, the entire chronic illness landscape changes shape.
Mohammed Attallah is the founder of Biomelogic and the developer of the Host Capacity Model framework for chronic gut and immune dysfunction. He works as an independent systems biology analyst alongside prescribing physicians, with cases drawn from complex MCAS, SIBO, long COVID, perimenopause, hEDS POTS triad, and treatment resistant chronic illness presentations. Companion pieces on the SIBO breath test, why protocols fail at two weeks, the brain fog mechanism, histamine intolerance beyond DAO, the perimenopause flare pattern, and the stool test paradox are all available at www.biomelogic.net.